Nutralife Biosciences Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Nutralife Biosciences last-minute Real Value cannot be determined due to lack of data. The latest price of Nutralife Biosciences is $0.0. Our model forecasts the value of Nutralife Biosciences from analyzing the firm fundamentals such as Return On Equity of -14.26, shares outstanding of 176.62 M, and Operating Margin of (3.80) % as well as examining its technical indicators and probability of bankruptcy.
Nutralife Biosciences Total Value Analysis
Nutralife Biosciences is now forecasted to have valuation of 11.61 M with market capitalization of 6.62 M, debt of 10 K, and cash on hands of 51.8 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Nutralife Biosciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
11.61 M | 6.62 M | 10 K | 51.8 K |
Nutralife Biosciences Investor Information
About 46.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.03. Nutralife Biosciences had not issued any dividends in recent years. Based on the key indicators related to Nutralife Biosciences' liquidity, profitability, solvency, and operating efficiency, Nutralife Biosciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Nutralife Biosciences Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Nutralife Biosciences has an asset utilization ratio of 12.92 percent. This implies that the Company is making $0.13 for each dollar of assets. An increasing asset utilization means that Nutralife Biosciences is more efficient with each dollar of assets it utilizes for everyday operations.Nutralife Biosciences Ownership Allocation
Nutralife Biosciences maintains a total of 176.62 Million outstanding shares. Nutralife Biosciences holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Nutralife Biosciences Profitability Analysis
The company reported the previous year's revenue of 626.62 K. Net Loss for the year was (5.83 M) with profit before overhead, payroll, taxes, and interest of 83.59 K.Nutralife Biosciences Growth Indicators
Investing in growth stocks can be very risky. If the company such as Nutralife Biosciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 146.3 M | |
| Retained Earnings | -47.6 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Nutralife Pink Sheet
If you are still planning to invest in Nutralife Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nutralife Biosciences' history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |